University of Houston receives $20M donation, renames nursing school

gift of health care

The University of Houston's nursing program has received a significant gift to address the nursing industry's workforce shortage. Photo via UH.edu

A University of Houston alumnus and his wife have donated a historic gift to strengthen nursing education and research at his alma mater.

Andy and Barbara Gessner's $20 million gift to the UH College of Nursing was announced this week during National Nurses Week. The contribution will go toward scholarships and fellowships for students, as well as support programming and research to address the shortage of nurses in the workforce. The college has been renamed in honor of the gift to the Andy and Barbara Gessner College of Nursing.

The Gessners’ support of the College of Nursing is inspired by the many caring and giving nurses they know, including their late mothers, who were both nurses. Gertrude Smith Gessner and Mildred Roberson Pottenger dedicated their lives to delivering compassionate health care to their patients and serving their communities with distinction.

“We believe in nurses and we need more of them right now,” Andy Gessner, whose mother and mother-in-law were both nurses, says in a news release. “We’re all going to need a nurse at some time in our lives, and there's just not enough in the workforce or being educated for the future. The primary intent of our gift is to make more nurses available when we need them, now and in the future.”

By 2025, according to the Bureau of Labor Statistics, there will be a shortage of almost 200,000 registered nurses and a rise in demand of 12 percent between now and 2029.

“The silver tsunami is coming,” says Barbara Gessner in the release. “We are certainly going to need more nurses as the population gets older, so the medical profession will be put to the test. It's always been an honorable profession, and we believe in that tender, compassionate care that nurses provide.”

The donation will create three endowed professorships, two of the which will be matched one-to-one as part of the University’s “$100 Million Challenge” for chairs and professorships. Additional endowments funded by the gift, according to UH, will go toward research, nursing education, clinical learning, scholarships, graduate student fellowships, adjunct faculty support and and more.

“Our college of Nursing has been a leader in preparing highly skilled nurses for the workforce, and this comprehensive gift from Andy and Barbara Gessner will take it to the next level,” says UH President Renu Khator. “We are forever grateful to the Gessners for their vision, commitment and passion for nursing education so that we can educate more nurses who will make a positive impact on the lives of patients and in the health care industry.”

Kathryn Tart is the founding dean of the Gessner College of Nursing, and she believes the gift will have a significant impact on the university as well as the industry as a whole.

“This gift will have a lasting impact on the nursing profession and our great city, state and beyond for many years to come,” she says. “We will be able to attract more top faculty and students and increase our research endeavors to further the University’s mission of becoming a top 50 public university. We are so grateful to the Gessners for their support and vision to address the severe nursing shortage.”

In 2019, the Gessner Family Nursing Scholarship was established. To date, the scholarship has provided full tuition to 19 students in the Traditional BSN program.

“Our legacy will not be about what we did, it's what this gift will do,” says Andy Gessner. “We hope that in the coming years, the Gessner College of Nursing will be recognized for excellence and for creating more nurses.”

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

4 Houston innovators to know for February 2025

Featured Innovators

Editor's note: Houston researchers and professors have been in the national spotlight as of late. For InnovationMap's February roundup of Innovators to Know, we focus on trailblazers from UH, Rice, and beyond, who have recently garnered presidential awards in STEM, revealed research breakthroughs, and more. Meet our featured innovators below.

Donna Stokes, physics professor, University of Houston

Donna Stokes. Courtesy photo

The White House recently recognized UH physics professor Donna Stokes for her outstanding mentoring in STEM disciplines with the Presidential Awards for Excellence in Science, Mathematics and Engineering Mentoring.

The National Science Foundation manages the PAESMEM awards, and the White House Office of Science and Technology Policy selects honorees.

“Spotlighting STEM educators, researchers and mentors is important to demonstrate the critical role they play in developing and encouraging students to pursue STEM degrees and careers,” Stokes said in a news release. “It is imperative to have STEM educators who can foster the next generation of scientists to address local and national scientific challenges.” Continue reading.

Allison Master, associate professor, University of Houston

Allison Master. Courtesy photo

Allison Master, an assistant professor at the University of Houston, is the first from the college to be awarded the Presidential Early Career Award for Scientists and Engineers.

Master, who works in the Department of Psychological, Health and Learning Sciences at the UH College of Education, is one of 400 scientists and engineers to receive the honor from the Biden administration. The award recognizes those who “show exceptional potential for leadership early in their research careers,” according to a statement.

Master’s research in the Identity and Academic Motivation Lab at UH involves how societal stereotypes contribute to gender gaps in motivation to pursue STEM. Her study also explored ways to counter the stereotypes through educational strategies that make students feel that they belong, what drives children’s interest in STEM and the role of social connections. Her efforts resulted in millions of dollars in grants from the U.S. Department of Education’s Institute of Education Sciences, the National Science Foundation, and other organizations, according to UH. Continue reading.

Xiaoyu Yang, graduate student, Rice University 

Xiaoyu Yang, a graduate student at Rice, is the lead author on a study published in the journal Science on smart cell design. Photo by Jeff Fitlow/ Courtesy Rice University

Bioengineers at Rice University have developed a “new construction kit” for building custom sense-and-respond circuits in human cells, representing a major breakthrough in the field of synthetic biology, which could "revolutionize" autoimmune disease and cancer therapeutics.

In a study published in the journal Science, the team focused on phosphorylation, a cellular process in the body in which a phosphate group is added to a protein, signaling a response. In multicellular organisms, phosphorylation-based signaling can involve a multistage, or a cascading-like effect. Rice’s team set out to show that each cycle in a cascade can be treated as an elementary unit, meaning that they can be reassembled in new configurations to form entirely novel pathways linking cellular inputs and outputs.

“This work brings us a whole lot closer to being able to build ‘smart cells’ that can detect signs of disease and immediately release customizable treatments in response,” said Xiaoyu Yang, graduate student in the Systems, Synthetic and Physical Biology Ph.D. program at Rice and lead author on the study. Continue reading.

Dr. Peter Hotez

Dr. Peter Hotez, pictured here with Dr. Maria Elena Bottazzi. Photo courtesy of TMC

Houston vaccine scientist Dr. Peter Hotez can add one more prize to his shelf.

Hotez — dean of the National School of Tropical Medicine and professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, co-director of the Texas Children’s Center for Vaccine Development (CVD) and Texas Children’s Hospital Endowed Chair of Tropical Pediatrics — is no stranger to impressive laurels. In 2022, he was even nominated for a Nobel Peace Prize for his low-cost COVID vaccine.

His first big win of 2025 is this year’s Hill Prize, awarded by the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST).

Hotez and his team were selected to receive $500,000 from Lyda Hill Philanthropies to help fund The Texas Virosphere Project. The endeavor was born to help create a predictive disease atlas relating to climate disasters. Continue reading.

UH research team receives grant to fight aggressive pediatric cancer

cancer research

Researchers at the University of Houston have received a $3.2 million grant from the National Institutes of Health to help find innovative ways to treat Rhabdomyosarcoma, or RMS.

According to a statement from the university, RMS is a malignant soft tissue sarcoma that has a higher incidence in young children and is responsible for 8 percent of pediatric cancer cases with a relatively low survival rate.

One way UH is working on the issue is by studying how and why RMS cells, which are found most often in muscle tissue, divide uncontrollably without ever maturing into normal muscle cells. The researchers aim to tackle a target inside RMS cells known as TAK1, which plays a key role in regulating cell growth.

“By targeting TAK1, we aim to stop the cancer at its source and help the cells develop normally,” Ashok Kumar, the Else and Philip Hargrove Endowed Professor of Drug Discovery at the UH College of Pharmacy and director of the Institute of Muscle Biology and Cachexia, said in a news release. “This approach could lead to new and better treatments for RMS.”

According to UH, preliminary results demonstrated that TAK1 is highly activated in embryonal RMS cells, which are found in younger children; alveolar RMS cells, which are found in older children and teens; and human RMS samples. This suggests that the protein plays a major role in the development of this form of cancer.

The team still aims to uncover how the protein helps RMS cancer grow and plans to evaluate how blocking TAK1 can be used as a therapeutic.

“Blocking TAK1, either by changing the genes (genetic approaches) or using drugs (pharmacological approaches), can stop certain harmful behaviors in cancer cells,” Kumar added. “This was tested both in lab-grown cells and in living models, showing that TAK1 is a key target to control RMS cancer’s spread and aggressiveness, and inhibits tumor formation.”

Texas A&M expands innovative Dog Aging Project via $7 million grant

pet project

The Texas A&M College of Veterinary Medicine and Biomedical Sciences has received a $7 million grant from the National Institutes of Health to support its Dog Aging Project.

The DAP is a research project that was launched in 2019 by Texas A&M and the University of Washington School of Medicine and has enrolled over 50,000 dogs to date, according to a release. The program studies various breeds of companion dogs and studies the effects of aging to help develop a better understanding of what can lead to an expanded, healthy canine life, which can also assist with human aging knowledge.

The NIH funds will be used to expand a clinical trial studying how the drug rapamycin, also called sirolimus, can extend the lives of companion dogs.

The project, known as Test of Rapamycin In Aging Dogs (TRIAD), is the third DAP clinical trial involving the drug rapamycin. The drug has previously been used as an immunosuppressant during organ transplants in humans. Past DAP studies reported that the drug appears to improve cardiac function in dogs.

“Rapamycin works by modifying the cells’ energy balance and energy handling,” Dr. Kate Creevy, DAP chief veterinary officer and a professor in the VMBS’ Department of Small Animal Clinical Sciences, said in a news release. "It seems to mimic the effects that happen in people or animals who do intermittent fasting. There is a lot of interest in intermittent fasting as a technique that can improve health, particularly healthy aging, and some of the pharmaceutical effects of rapamycin make the same changes at the cellular level.”

So far, 170 dogs are in the trial at 20 sites, with the goal of expanding to 580 dogs enrolled in multiple cities across the country. Dogs must be over 7 years old and in good general health to participate. They should also weigh at least 44 pounds. Owners are required to bring their dogs to one of TRIAD’s participating clinical sites every six months for three years. The Texas clinical sites are in College Station and North Texas.

“Dogs experience many of the age-related cognitive, sensory, neuropathologic and mobility changes that are common in older humans,” Dr. May Reed, a geriatrician at the University of Washington School of Medicine and another primary investigator in the study, said in the release. “The possibility that rapamycin might delay any of the alterations that contribute to cognitive impairment and functional decline is very exciting and has huge translational potential.”

“We get to learn how to support both dog and human aging at the same time. Our research is also powered by owners’ commitments to the health of their dogs, and that’s what makes our work both possible and meaningful,” Creevy added. “We’re very grateful to them.”

View All Listings